Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-05

Clinical Trial Update: Brain Changes in Psoriasis After Secukinumab Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating potential brain changes in psoriasis patients treated with secukinumab. Results were posted on 2025-06-05.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosentyx (secukinumab)

Snippet

Sponsor: University of Miami | Conditions: Psoriasis, Healthy | Phase 4 | Status: COMPLETED | Results posted: 2025-06-05